glp 1 agonist treatment GLP-1 receptor agonists show promise in treating substance use disorders New GLP-1 Guidelines for Type

The report highlighted the limitations of BMI, and instead the Commission recommends combining BMI with waist circumference, waist-to-height ratio, and clinical markers of organ dysfunction to diagnose obesity accurately

Losing muscle during weight loss can lower your metabolism and make long-term weight maintenance more challenging.

Public reimbursement accounts for only 15% of the market, primarily covering patients with severe obesity and documented metabolic complications

Understanding both conditions and their interconnections is essential for evaluating potential therapeutic approaches and managing patient expectations appropriately

& Pavli-Renar, I

Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: A randomised, double-blind, active-comparator, non-inferiority clinical trial